Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder

被引：0
|
作者：
Kennedy, S. [1 ]
Grouin, J. [2 ]
Cadour, S. [3 ]
Robert, V. [3 ]
Picarel-Blanchot, F. [4 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Rouen, INSERM, U1219, Populat Hlth, Rouen, France
[3] IRIS, Biostat Dept, Suresnes, France
[4] IRIS, Neuropsychiat Innovat Therapeut Pole, Suresnes, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
METAANALYSIS;
D O I：
10.1016/S0924-977X(16)31450-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.007
引用
下载
收藏
页码：S457 / S458
页数：2
相关论文
共 50 条
  • [31] Short-term cerebral blood flow variability in major depressive disorder
    Duschek, Stefan
    Hoffmann, Alexandra
    Reyes del Paso, Gustavo A.
    Montoro, Casandra, I
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 282 : 1120 - 1124
  • [32] Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Praksh S.
    Serretti, Alessandro
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2015, 40 (03): : 174 - 186
  • [33] EFFICACY AND SAFETY OF BREXPIPRAZOLE AS ADJUNCTIVE TREATMENT IN MAJOR DEPRESSIVE DISORDER: OVERVIEW OF FOUR SHORT-TERM STUDIES
    Hobart, M.
    Zhang, P.
    Weiss, C.
    Meehan, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 : 144 - 144
  • [34] Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies
    Thase, Michael E.
    Zhang, Peter
    Weiss, Catherine
    Meehan, Stine Rasmussen
    Hobart, Mary
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (15) : 1907 - 1916
  • [35] Questions Raised by the Failure of a Trial of Short-Term Psychodynamic Therapy Versus Pharmacotherapy for Major Depressive Disorder
    Kocsis, James H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (01) : 64 - 65
  • [36] The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder: A Placebo-Controlled Study
    Heun, Reinhard
    Ahokas, Antti
    Boyer, Patrice
    Gimenez-Montesinos, Natalia
    Pontes-Soares, Fernando
    Olivier, Valerie
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (06) : 587 - 594
  • [37] Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder: subgroup analyses
    Vieta, E.
    Loft, H.
    Florea, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S458 - S458
  • [38] Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients
    Quera-Salva, Maria-Antonia
    Hajak, Goeran
    Philip, Pierre
    Montplaisir, Jaques
    Keufer-Le Gall, Sophie
    Laredo, Judith
    Guilleminault, Christian
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (05) : 252 - 262
  • [39] EFFICACY AND SAFETY OF 3 AGOMELATINE DOSE REGIMENS (10, 25, 25-50 MG) VERSUS PLACEBO IN OUT-PATIENTS SUFFERING FROM MODERATE TO SEVERE MAJOR DEPRESSIVE DISORDER
    Kennedy, S. H.
    Avedisova, A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [40] Efficacy of 3 agomelatine dose regimens versus placebo in major depressive disorder (MDD) patients according to the level of severity at baseline
    Kennedy, S. H.
    Avedisova, A.
    Picarel-Blanchot, F.
    De Bodinat, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S408 - S408
12345